Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADIL Adial Pharmaceuticals

Market Closed 11-22 16:00:00 EST

1.01

-0.01

-0.98%

盘后0.9999

-0.01-1.00%

19:57 EST

High1.02	Low0.9900	Vol149.48K
Open1.02	D1 Closing1.02	Amplitude2.94%
Mkt Cap6.47M	Tradable Cap6.35M	Total Shares6.41M
T/O149.95K	T/O Rate2.38%	Tradable Shares6.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":1.01,"timestamp":1732309200000,"preClose":1.02,"halted":0,"volume":149480,"hourTrading":{"tag":"盘后","latestPrice":0.9999,"preClose":1.01,"latestTime":"19:57 EST","volume":2686,"amount":2690.1821,"timestamp":1732323476823},"delay":0,"floatShares":6290530,"shares":6405781,"eps":-3.40639,"marketStatus":"Market Closed","change":-0.01,"latestTime":"11-22 16:00:00 EST","open":1.02,"high":1.02,"low":0.99,"amount":149952.50628,"amplitude":0.029412,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.40639,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732525200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":1.02,"preHourTrading":{"tag":"盘前","latestPrice":1.0008,"preClose":1.02,"latestTime":"09:27 EST","volume":4573,"amount":4609.633845699999,"timestamp":1732285646224},"postHourTrading":{"tag":"盘后","latestPrice":0.9999,"preClose":1.01,"latestTime":"19:57 EST","volume":2686,"amount":2690.1821,"timestamp":1732323476823},"volumeRatio":0.9250160272192167,"impliedVol":3.592,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADIL/tweets","defaultTab":"tweets","newsList":[{"id":"2484298437","title":"Adial Pharmaceuticals Advances AD04 with Promising Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2484298437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484298437?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:37","pubTimestamp":1731965826,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) just unveiled an announcement. Adial Pharmaceuticals has completed a significant pharmacokinetics study for its l...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-advances-ad04-with-promising-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-advances-ad04-with-promising-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2483580375","title":"Maxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483580375","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483580375?lang=en_us&edition=fundamental","pubTime":"2024-11-16 04:35","pubTimestamp":1731702912,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Hold rating on Adial Pharmaceuticals (ADIL – Research Report). The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-hold-rating-for-adial-pharmaceuticals-adil?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-hold-rating-for-adial-pharmaceuticals-adil?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL"],"gpt_icon":0},{"id":"2483385495","title":"BUZZ-U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, Sonos","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483385495?lang=en_us&edition=fundamental","pubTime":"2024-11-15 00:17","pubTimestamp":1731601060,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, SonosEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4N3ML1CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUT","PTCT","ALSN","RIOT","TPR","VTR","AAP","2NVD.UK","COIN","DIS","NEM","HIMS","NVDS","PZZA","LU0724617625.USD","HLT","AAL","CNH","GWH","NVD","NVDX","HROW","DOCS","LU0154245673.USD","CSCO","AESI","ACIU","NVDL","OKLO","SNVD.UK","BW","AMGN","NVDU","3NVD.UK","NVDA","NVDD","ZETA","CPB","LU2237443549.SGD","MRK","NVDS.UK","NVD3.UK","LU0082616367.USD","MARA","ADIL","SONO","NVDY","NVD2.UK","MA"],"gpt_icon":1},{"id":"2483801371","title":"Adial Pharmaceuticals Shares up 18% on Data for Alcohol Abuse Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2483801371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483801371?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:34","pubTimestamp":1731594843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nFWN3ML16W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2483062578","title":"Adial Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483062578","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483062578?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:16","pubTimestamp":1731593803,"startTime":"0","endTime":"0","summary":"* Adial Pharmaceuticals Inc    reported a quarterly adjusted loss of 38 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Adial Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL"],"gpt_icon":0},{"id":"2483805772","title":"BUZZ-Adial Pharma jumps on data for alcohol abuse drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2483805772","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483805772?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:03","pubTimestamp":1731593002,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Adial Pharmaceuticals    rise 12% to $1.11 premarket    ** Co says AD04, its lead drug candidate being developed to treat alcohol-use disorder in heavy-drinking patients, showed safety and tolerability consistent with an existing treatment   ** Study enrolled 30 healthy adult volunteers, ADIL says   ** Says completion of the study satisfied an FDA requirement for the upcoming late-stage trials of the oral drug   ** Co plans to meet with FDA in Q4 2024 with the results of the study   ** Up to last close, stock down ~47% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2483808136","title":"Adial Pharmaceuticals Announces Positive Topline Results From the Ad04-103 Pharmacokinetics Study of Ad04 for the Treatment of Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2483808136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483808136?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:30","pubTimestamp":1731591001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUAZNKCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2483808116","title":"Adial Pharmaceuticals : Continued Excellent Safety & Tolerability Findings, Consistent With Extensive Human Use Experience With Ondansetron","url":"https://stock-news.laohu8.com/highlight/detail?id=2483808116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483808116?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:30","pubTimestamp":1731591001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUAZNKCG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2483089778","title":"Adial Pharmaceuticals Inc - Study Completion Satisfies FDA Requirement for Phase 3 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2483089778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483089778?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:30","pubTimestamp":1731591001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUAZNKCG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2483808775","title":"Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2483808775","media":"GlobeNewswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483808775?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:30","pubTimestamp":1731591000,"startTime":"0","endTime":"0","summary":"Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981205/26135/en/Adial-Pharmaceuticals-Announces-Positive-Topline-Results-from-the-AD04-103-Pharmacokinetics-Study-of-AD04-for-the-Treatment-of-Alcohol-Use-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","LU0426417589.USD","BK4125","LU0426412945.USD","AUD","BK4218","LU2238339852.HKD","LU0994945656.USD","BK4181","PK","LU0345774631.USD","LU1043141123.HKD","BK4007"],"gpt_icon":1},{"id":"2483877458","title":"EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877458","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483877458?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:00","pubTimestamp":1731589248,"startTime":"0","endTime":"0","summary":"Thursday, Adial Pharmaceuticals Inc  said it has completed a pharmacokinetics  study of AD04 for Alcohol Use Disorder  in heavy drinking patients .This data will help the company optimize study design elements needed for the upcoming Phase 3 clinical trial of AD04.Completing the study also satisfied an FDA requirement for the upcoming Phase 3 trials of AD04.Also Read: EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder. The single-center, relative bioavailability, open-label study enrolled 30 healthy adult volunteers in two cohorts.Cohort 1 (n=6) was a randomized, open-label, 2-sequence, 2-period crossover study to evaluate the PK variability of ondansetron from AD04 0.33 and 0.99mg.Cohort 2  was a randomized, open-label, 6-sequence, 4-period crossover study to evaluate the relative bioavailability of the AD04 0.33mg tablet to a marketed ondansetron 4mg tablet, dose proportionality of ondanset","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/NN8L9EBK1a6OmUox7ET6Sg--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/84b45169683bc53fb4bd2140b9934f52","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/NN8L9EBK1a6OmUox7ET6Sg--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/84b45169683bc53fb4bd2140b9934f52"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-adial-pharmaceuticals-reveals-topline-130048798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4181","LU1043141123.HKD","LU0994945656.USD","AUD","ADIL","PK","LU0426412945.USD","BK4218","LU0426417589.USD","LU0345774631.USD","BK4125","LU2238339852.HKD"],"gpt_icon":0},{"id":"2483836698","title":"Adial Pharmaceuticals Q3 Net Loss $2.2M","url":"https://stock-news.laohu8.com/highlight/detail?id=2483836698","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483836698?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:48","pubTimestamp":1731505694,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Q3 Net Loss $2.2M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41939045/adial-pharmaceuticals-q3-net-loss-2-2m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2483688841","title":"Adial Pharmaceuticals expects cash to fund operations into second half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2483688841","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483688841?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:36","pubTimestamp":1731504985,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents were $5.2 million as of September 30, 2024, compared to $2.8 million as of December 31, 2023. The Company believes that i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-expects-cash-to-fund-operations-into-second-half-of-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-expects-cash-to-fund-operations-into-second-half-of-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2481483975","title":"Adial Pharmaceuticals Inc  expected to post a loss of 44 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483975","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481483975?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:48","pubTimestamp":1731080926,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Inc  expected to post a loss of44cents a share - Earnings Preview Adial Pharmaceuticals Inc ADIL.OQ ADIL.O is expected to show no change in quarterly revenue when it reports  res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF24O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL"],"gpt_icon":0},{"id":"2481507942","title":"Adial Pharmaceuticals Appoints New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481507942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481507942?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:15","pubTimestamp":1730816108,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) just unveiled an update. Adial Pharmaceuticals has appointed Vinay Shah as their new Chief Financial Officer, eff...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-appoints-new-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2481501957","title":"Adial Pharmaceuticals Inc - Truluck to Remain as CFO Until November 15, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481501957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481501957?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:30","pubTimestamp":1730813401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241105:nTUAB5S0JP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRPX","ADIL"],"gpt_icon":0},{"id":"2481501559","title":"Adial Pharmaceuticals Inc - Joseph Truluck Resigns as CFO of Adial Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2481501559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481501559?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:30","pubTimestamp":1730813401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241105:nTUAB5S0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL","VRPX"],"gpt_icon":0},{"id":"2481501367","title":"Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481501367","media":"THOMSON REUTERS","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481501367?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:30","pubTimestamp":1730813401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241105:nTUAB5S0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL","VRPX"],"gpt_icon":0},{"id":"2481013315","title":"Press Release: Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481013315","media":"Dow Jones","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481013315?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:30","pubTimestamp":1730813400,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., Nov. 05, 2024  -- Adial Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Vinay Shah as the Company's Chief Financial Officer, effective November 16, 2024.On November 1, 2024, Joseph Truluck notified the CEO of the Company of his decision to resign from his position as the Company's Chief Financial Officer to pursue other opportunities. Mr. Truluck will remain CFO of the Company until November 15, 2024 and has entered into a consulting agreement with Adial, through March 31, 2025, in order to aid in an orderly transition. Mr. Truluck's resignation was no","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4585","LU1043141123.HKD","LU0994945656.USD","BK4099","AUD","ADIL","LU0426412945.USD","TM","03160","LU0426417589.USD","LU0345774631.USD","BK4125","BK4555","LU2238339852.HKD"],"gpt_icon":1},{"id":"2477587874","title":"Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2477587874","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477587874?lang=en_us&edition=fundamental","pubTime":"2024-10-23 21:00","pubTimestamp":1729688400,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., Oct.  23, 2024  (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/23/2967823/0/en/Adial-Pharmaceuticals-to-Present-at-the-2024-ThinkEquity-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4125","WRD","AUD","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adialpharma.com","stockEarnings":[{"period":"1week","weight":-0.0472},{"period":"1month","weight":-0.0561},{"period":"3month","weight":0.0434},{"period":"6month","weight":-0.192},{"period":"1year","weight":-0.528},{"period":"ytd","weight":-0.457}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.11348},{"month":2,"riseRate":0.333333,"avgChangeRate":0.054105},{"month":3,"riseRate":0,"avgChangeRate":-0.126633},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.03704},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.095363},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.091774},{"month":7,"riseRate":0.5,"avgChangeRate":0.019629},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.065704},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.033423},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.173095},{"month":11,"riseRate":0.571429,"avgChangeRate":0.175324},{"month":12,"riseRate":0.333333,"avgChangeRate":0.057024}],"exchange":"NASDAQ","name":"Adial Pharmaceuticals","nameEN":"Adial Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adial Pharmaceuticals,ADIL,Adial Pharmaceuticals股票,Adial Pharmaceuticals股票老虎,Adial Pharmaceuticals股票老虎国际,Adial Pharmaceuticals行情,Adial Pharmaceuticals股票行情,Adial Pharmaceuticals股价,Adial Pharmaceuticals股市,Adial Pharmaceuticals股票价格,Adial Pharmaceuticals股票交易,Adial Pharmaceuticals股票购买,Adial Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}